Cargando…
Pharmacogenetics: detecting sensitive populations.
Risk assessment models strive to predict risks to humans from toxic agents. Safety factors and assumptions are incorporated into these models to allow a margin of error. In the case of cancer, substantial evidence shows that the carcinogenic process is a multistage process driven by the interaction...
Autor principal: | Shields, P G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566765/ https://www.ncbi.nlm.nih.gov/pubmed/7737047 |
Ejemplares similares
-
Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010) -
Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach
por: Chen, F S, et al.
Publicado: (2015) -
Evaluation of population‐level pharmacogenetic actionability in Alabama
por: Davis, Brittney H., et al.
Publicado: (2021) -
Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019) -
The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)